COMPARATIVE EFFECTIVENESS OF THE COMBINATIONS OF DIURETICS AND DIHYDROPYRIDINE AND NONDIHYDROPYRIDINE CALCIUM ANTAGONISTS IN PATIENTS WITH ARTERIAL HYPERTENSION
Abstract
About the Authors
B. G. IskenderovRussian Federation
E. V. Gridneva
Russian Federation
O. N. Sisina
Russian Federation
L. F. Burmistrova
Russian Federation
S. V. Saushkina
Russian Federation
References
1. Диагностика и лечение артериальной гипертензии. Российские национальные рекомендации ВНОК. – М., 2008.
2. Марцевич С.Ю. Антагонисты кальция: выбор терапии при артериальной гипертонии// Артериальная гипертензия 2004; 4: 193–8.
3. Недогода С.В. Диуретики при артериальной гипертензии. Москва, 2008.
4. Чазова И.Е., Бойцов С.А., Остроумова О.Д. Комбинированная терапия больных артериальной гипертонией. Методическое письмо. М., 2004.
5. Abernethy DR., Schwartz JB. Drug therapy: Calcium-Antagonists Drugs // N Engl J Med 1999; 341: 1447–57.
6. Black H.R., Elliott W.J., Grandits G. et al. Principal results of the Controlled Onset Verapamil Investigation of Cardiovascular End Points (CONVINCE) trial // JAMA. 2003; 289: 2073–82.
7. Brown MJ, Palmer CR, Castaigne A. et al. Morbidity and mortality in patients randomized to double-blind treatment with a long-acting calcium channel blocker or diuretic in the international nifedipine GITS study: Intervention as a Goal in Hypertension Treatment (INSIGHT)// Lancet 2000; 356: 366–72.
8. Devereux R, Reichek N. Echocardiographic assessment of left ventricular mass in man. Anatomic validation of the method// Circulation 1977; 55: 613–18.
9. Eisenberg MJ, Brox A, Bestawros AN. Calcium channel blockers // Am J Med. 2004; 116: 35–43.
10. Guidelines for the management of arterial hypertension. The Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (EHS) and the European Society of Cardiology (ESC)// Eur Heart J 2007; 28: 1462-1536.
11. Lefrandi JD, Heitmann J, Sevre K et al. The effects of dihydropyridine and phenylalkylamine calcium antagonist classes on autonomic function in hypertension: the VAMPHYRE study// Am J Hypertens 2001; 14: 1083-89.
12. Noll G, Luscher TF. Comparative pharmacological properties among calcium channel blockers: T-channel versus L-channel blockade// Cardiology. 1998; 89: 10–15.
13. Opie L, Schall R. Evidence-based evaluations of calcium channel blockers for hypertension// JACC 2002; 39: 315–22.
14. Staessen J, Ji-Guang Wang, Thijs L. Calcium channel blockade and cardiovascular prognosis: recent evidence from clinical outcome trail// Am J Hypertens 2002; 15: 85S–93S.
15. The ALLHAT Officers and Coordinations. Major outcomes in high-risk hypertensive patients randomized to ACE inhibitor or calcium channel blocker versus diuretic (ALLHAT)// JAMA 2002; 288: 2981–97.
Review
For citations:
Iskenderov B.G., Gridneva E.V., Sisina O.N., Burmistrova L.F., Saushkina S.V. COMPARATIVE EFFECTIVENESS OF THE COMBINATIONS OF DIURETICS AND DIHYDROPYRIDINE AND NONDIHYDROPYRIDINE CALCIUM ANTAGONISTS IN PATIENTS WITH ARTERIAL HYPERTENSION. Russian Journal of Cardiology. 2010;(6):34-39. (In Russ.)